DAPAFON M EXTRA – Dapagliflozin & Metformin Hydrochloride Extended Release Tablets
Description:
Dapagliflozin 10mg + Metformin (ER) 1000 mg combine two antidiabetic agents, both has different mechanism of action yet synergistic mechanisms to improve glycemic control in adults with Type 2 Diabetes Mellitus. Dapagliflozin, a selective SGLT2 inhibitor, lowers blood glucose by promoting urinary glucose excretion, while Metformin (ER) reduces hepatic glucose production and enhances peripheral insulin sensitivity. Together, they provide effective blood sugar control, help in weight management, and reduce cardiovascular risks with convenient once-daily dosing.
Key Points
✅Dual Mechanism Glycemic Control: Combines insulin-independent glucose excretion with improved insulin sensitivity for optimal blood sugar regulation.
✅Cardio-Metabolic Advantage: Supports weight reduction and improves cardiovascular outcomes in Type 2 Diabetes patients.
✅Enhanced Tolerability & Compliance: Extended-release Metformin ensures gastrointestinal comfort and once-daily dosing convenience.
Targeted Specialties:
✅Diabetology
✅Endocrinology
✅General Medicine
Disclaimer: To be administered only under the supervision of a qualified healthcare professional. Intended for use by registered medical practitioners. Not for public promotion.











